Canada is holding firm on one of the more restrictive approaches to legal nicotine pouch access among countries where the products are authorised.
Federal Health Minister Marjorie Michel said this week that she is not considering loosening rules that restrict authorised nicotine pouches to pharmacies. The comments follow calls for wider retail availability, with supporters arguing that easier access to regulated products could provide an alternative to unauthorised pouches already circulating in Canada. Michel acknowledged that illicit sales, particularly online, remain a challenge but indicated that broader retail access is not currently being considered.¹
The debate presents a useful test of regulatory effectiveness. Canada’s rules were introduced with clear public-health objectives, particularly youth protection and smoking cessation. The question now is whether those objectives are being achieved in practice and how the framework should respond if unauthorised supply continues alongside a tightly restricted legal market.
Canada Treats Pouches as Smoking-Cessation Products
Canada regulates authorised tobacco-free nicotine pouches as nicotine replacement therapies rather than conventional consumer nicotine products. Health Canada’s rules require certain oral NRT products, including pouches, to be sold by pharmacists or under pharmacist supervision and kept behind pharmacy counters. Flavours are restricted to mint, menthol or combinations of the two.²
Health Canada also clarified the regulatory status of nicotine buccal pouches in January 2026. Pouches containing 4 mg or less of nicotine per dosage unit can be regulated as non-prescription Natural Health Products, while products containing more than 4 mg are prescription drugs.³
The rationale is primarily protective. Restricting access and flavours is intended to reduce youth appeal and recreational use while preserving availability for adults using authorised products to quit smoking.²
That objective is understandable. Nicotine is addictive, and preventing uptake among young people and non-users should remain an important part of nicotine regulation. But regulatory effectiveness ultimately depends on what happens outside the framework as well as within it.
The Unauthorised Market Complicates the Picture
Health Canada acknowledges that unauthorised nicotine pouches continue to appear through online sellers, convenience stores, gas stations and other retailers.² In July 2026, for example, authorities recalled several unauthorised nicotine pouch products, including products containing nicotine strengths ranging from 4 mg to 15 mg per pouch.⁴
This does not demonstrate that pharmacy restrictions caused the unauthorised market. Demand, online commerce, cross-border supply and enforcement capacity can all influence illicit availability.
It does, however, create an important policy question. If adults encounter a highly restricted legal market alongside a more accessible unauthorised one, regulators need to understand how consumers respond.
Supporters of broader retail access argue that making authorised products more accessible could help compete with illicit supply. Tobacco-control organisations take a different view, arguing that enforcement should be strengthened rather than access rules relaxed.¹ Neither position should simply be assumed correct. The relevant question is which approach produces better real-world outcomes.
Youth Protection and Adult Access Can Coexist
Canada’s experience also illustrates a broader challenge in nicotine regulation: protecting young people while providing appropriate access for adults who smoke.
These objectives do not necessarily require identical policy responses. Age restrictions, retailer enforcement, online age verification, responsible marketing requirements, product standards and packaging controls can all help reduce youth access. Whether pharmacy-only distribution provides additional benefits sufficient to justify its access limitations is an empirical question that should be evaluated using evidence.
The same applies to nicotine strength and flavours. Canada has chosen relatively restrictive limits as part of its NRT framework. Those rules should be assessed according to whether they support smoking cessation, discourage youth initiation and maintain a viable regulated alternative to unauthorised products.
Judge the Model by Its Outcomes
Canada does not necessarily need to abandon its pharmacy-based approach. Nor should the existence of unauthorised products automatically justify wider retail availability.
But maintaining the current framework should involve continuing evaluation of whether it is delivering its intended public-health outcomes.
That means examining youth use, smoking cessation, consumer switching, legal product uptake, illicit purchasing and enforcement trends. If evidence shows that pharmacy restrictions meaningfully protect young people without creating significant barriers for adults using pouches to move away from cigarettes, that would support the model. If substantial demand continues migrating towards unauthorised products, policymakers should examine why and whether adjustments are needed.
For GINN, this is ultimately a question of regulatory performance rather than regulatory intent. Strong protections for young people remain essential, but restrictions should also be assessed for their effects on adult smokers, compliant markets and illicit supply.
Canada has chosen a tightly controlled pathway for nicotine pouches. The next question is increasingly important: is it working as intended?
Source
The Canadian Press, 23 September 2026. Health Minister Marjorie Michel said the government is not considering loosening nicotine pouch restrictions while acknowledging challenges surrounding illicit and online sales.
